Rationale, design and prerandomization data for a cluster randomized trial to assess the effect of a digitally enabled quality improvement intervention on LDL-C control in established atherosclerotic cardiovascular disease patients: the SAPPHIRE-LDL trial (2025)
- Authors:
- Autor USP: SANTOS FILHO, RAUL DIAS DOS - FM
- Unidade: FM
- DOI: 10.1016/j.ahj.2025.01.019
- Subjects: DOENÇAS CARDIOVASCULARES; ENSAIO CLÍNICO CONTROLADO RANDOMIZADO; COLESTEROL
- Agências de fomento:
- Language: Inglês
- Objetivos de Desenvolvimento Sustentável (ODS):
03. Saúde e bem-estar
- Imprenta:
- Source:
- Título: American Heart Journal
- ISSN: 0002-8703
- Volume/Número/Paginação/Ano: v. 284, p. 1-10, 2025
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
MACHLINE-CARRION, M. Julia et al. Rationale, design and prerandomization data for a cluster randomized trial to assess the effect of a digitally enabled quality improvement intervention on LDL-C control in established atherosclerotic cardiovascular disease patients: the SAPPHIRE-LDL trial. American Heart Journal, v. 284, p. 1-10, 2025Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/84856. Acesso em: 28 jan. 2026. -
APA
Machline-Carrion, M. J., Girotto, A. N., Raupp, P., Pereira, P. M., Monfardini, F., Santos Filho, R. D. dos, et al. (2025). Rationale, design and prerandomization data for a cluster randomized trial to assess the effect of a digitally enabled quality improvement intervention on LDL-C control in established atherosclerotic cardiovascular disease patients: the SAPPHIRE-LDL trial. American Heart Journal, 284, 1-10. doi:10.1016/j.ahj.2025.01.019 -
NLM
Machline-Carrion MJ, Girotto AN, Raupp P, Pereira PM, Monfardini F, Santos Filho RD dos, Santo K, Ray K, Cannon CP, Berwanger O. Rationale, design and prerandomization data for a cluster randomized trial to assess the effect of a digitally enabled quality improvement intervention on LDL-C control in established atherosclerotic cardiovascular disease patients: the SAPPHIRE-LDL trial [Internet]. American Heart Journal. 2025 ; 284 1-10.[citado 2026 jan. 28 ] Available from: https://observatorio.fm.usp.br/handle/OPI/84856 -
Vancouver
Machline-Carrion MJ, Girotto AN, Raupp P, Pereira PM, Monfardini F, Santos Filho RD dos, Santo K, Ray K, Cannon CP, Berwanger O. Rationale, design and prerandomization data for a cluster randomized trial to assess the effect of a digitally enabled quality improvement intervention on LDL-C control in established atherosclerotic cardiovascular disease patients: the SAPPHIRE-LDL trial [Internet]. American Heart Journal. 2025 ; 284 1-10.[citado 2026 jan. 28 ] Available from: https://observatorio.fm.usp.br/handle/OPI/84856 - Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps
- Characterizing familial chylomicronemia syndrome: baseline data of the APPROACH study
- Real-world outcomes with lomitapide use in paediatric patients with homozygous familial hypercholesterolaemia
- Sex disparity in the management and outcomes of dyslipidemia of diabetic patients in the Arabian Gulf: findings from the CEPHEUS study
- Vertebral bone density by quantitative computed tomography mirrors bone structure histomorphometric parameters in hemodialysis patients
- Effects of medication, treatment, and behavioral beliefs on intentions to take medication in patients with familial hypercholesterolemia
- Increased subclinical atherosclerosis burden in familial hypercholesterolemia phenotype [Editorial]: What do genetic defects tell us and what are the clinical implications?
- Sodium intake and prevalence of hypertension in elementary school students
- Clinical Genetic Testing for Familial Hypercholesterolemia
- Cardiovascular event reduction with PCSK9 inhibition among 1578 patients with familial hypercholesterolemia: results from the SPIRE randomized trials of bococizumab
Informações sobre o DOI: 10.1016/j.ahj.2025.01.019 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
